261 related articles for article (PubMed ID: 26839642)
1. Ablation techniques for primary and metastatic liver tumors.
Ryan MJ; Willatt J; Majdalany BS; Kielar AZ; Chong S; Ruma JA; Pandya A
World J Hepatol; 2016 Jan; 8(3):191-9. PubMed ID: 26839642
[TBL] [Abstract][Full Text] [Related]
2. Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences?
Vroomen LGPH; Petre EN; Cornelis FH; Solomon SB; Srimathveeravalli G
Diagn Interv Imaging; 2017 Sep; 98(9):609-617. PubMed ID: 28869200
[TBL] [Abstract][Full Text] [Related]
3. Locally ablative therapies for primary and metastatic liver cancer.
Li D; Kang J; Madoff DC
Expert Rev Anticancer Ther; 2014 Aug; 14(8):931-45. PubMed ID: 24746315
[TBL] [Abstract][Full Text] [Related]
4. Ablation of Intrahepatic Cholangiocarcinoma.
Sweeney J; Parikh N; El-Haddad G; Kis B
Semin Intervent Radiol; 2019 Oct; 36(4):298-302. PubMed ID: 31680720
[TBL] [Abstract][Full Text] [Related]
5. State of the ablation nation: a review of ablative therapies for cure in the treatment of hepatocellular carcinoma.
Salati U; Barry A; Chou FY; Ma R; Liu DM
Future Oncol; 2017 Jul; 13(16):1437-1448. PubMed ID: 28685607
[TBL] [Abstract][Full Text] [Related]
6. Alternative to surgery in early stage NSCLC-interventional radiologic approaches.
Lee KS; Pua BB
Transl Lung Cancer Res; 2013 Oct; 2(5):340-53. PubMed ID: 25806253
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation For Liver Tumors: A Review Of Literature.
Tameez Ud Din A; Tameez-Ud-Din A; Chaudhary FMD; Chaudhary NA; Siddiqui KH
Cureus; 2019 Jun; 11(6):e4994. PubMed ID: 31497425
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer ablation: technologies and techniques.
Alexander ES; Dupuy DE
Semin Intervent Radiol; 2013 Jun; 30(2):141-50. PubMed ID: 24436530
[TBL] [Abstract][Full Text] [Related]
9. Technology of irreversible electroporation and review of its clinical data on liver cancers.
Cohen EI; Field D; Lynskey GE; Kim AY
Expert Rev Med Devices; 2018 Feb; 15(2):99-106. PubMed ID: 29307242
[TBL] [Abstract][Full Text] [Related]
10. Update on ablative therapies of renal tumors.
D'Andrea D; Shariat SF; Klatte T
Curr Opin Urol; 2016 Sep; 26(5):410-6. PubMed ID: 27214581
[TBL] [Abstract][Full Text] [Related]
11. Ablative technologies in the management of patients with primary and secondary liver cancer: an overview.
Khan NA; Baerlocher MO; Owen RJ; Ho S; Kachura JR; Kee ST; Liu DM
Can Assoc Radiol J; 2010 Oct; 61(4):217-22. PubMed ID: 20188510
[TBL] [Abstract][Full Text] [Related]
12. Ablative Therapy in Non-HCC Liver Malignancy.
Robinson TP; Pebror T; Krosin ME; Koniaris LG
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831543
[TBL] [Abstract][Full Text] [Related]
13. Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies.
Kovács A; Iezzi R; Cellini F; Lancellotta V; Bischoff P; Carchesio F; Tagliaferri L; Kovács G; Gambacorta MA
J Contemp Brachytherapy; 2019 Dec; 11(6):589-600. PubMed ID: 31969919
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
[TBL] [Abstract][Full Text] [Related]
15. Thermal ablation for hepatocellular carcinoma: what's new in 2019.
Zhu F; Rhim H
Chin Clin Oncol; 2019 Dec; 8(6):58. PubMed ID: 31968982
[TBL] [Abstract][Full Text] [Related]
16. Japanese experience in ablation therapies for hepatocellular carcinoma.
Shiina S
Hepatol Res; 2007 Sep; 37 Suppl 2():S223-9. PubMed ID: 17877487
[TBL] [Abstract][Full Text] [Related]
17. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
El Dib R; Touma NJ; Kapoor A
BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
[TBL] [Abstract][Full Text] [Related]
18. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation.
Dunne RM; Shyn PB; Sung JC; Tatli S; Morrison PR; Catalano PJ; Silverman SG
Eur J Radiol; 2014 Apr; 83(4):632-8. PubMed ID: 24529593
[TBL] [Abstract][Full Text] [Related]
20. Ablation of Small Renal Masses.
Abdelsalam ME; Ahrar K
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100674. PubMed ID: 32591194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
